Companies: 10,795·Total market cap: $144.5T
Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NWPHFOTCHealthcare
$20.00
+$0.00(+0.00%)
Market Cap$416115900
P/E Ratio
52W High$20
52W Low$9.36
Overview

Newron Pharmaceuticals S.p.A. (NWPHF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NWPHF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$0.33nwphf eps ttm · nwphf earnings per shareEarnings history
PE Ratio (TTM)60.9×nwphf pe ratio ttm · nwphf price to earningsPE Ratio deep dive
Revenue (TTM)$60.9Mnwphf revenue ttm · nwphf annual revenueFull revenue history
Dividend YieldNo Dividenddoes nwphf pay dividends · nwphf dividend yieldDividend history
Shares Outstanding18.6Mnwphf shares outstanding · nwphf floatShares outstanding history
Next EarningsTBAnwphf earnings date · nwphf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$51.4M▲ +467.41% YoY
202220232024
newron pharmaceuticals s.p.a. revenue · nwphf revenue 2024
FY 2024Net Income$15.8M▲ +197.65% YoY
202220232024
newron pharmaceuticals s.p.a. net income · nwphf profit 2024
FY 2024EPS$0.85▲ +193.41% YoY
202220232024
nwphf eps · newron pharmaceuticals s.p.a. earnings per share 2024
TTM:Revenue: $60.9MNet Income: $6.5MEPS: $0.33View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y+221.54%

About Newron Pharmaceuticals S.p.A.

CEOStefan Weber
IPO DateAug 30, 2017
Employees22
CountryIT
Websitenewron.com

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and advancing treatments for disorders affecting the central and peripheral ner…

what is newron pharmaceuticals s.p.a. · nwphf stock overview · newron pharmaceuticals s.p.a. company profile · who is newron pharmaceuticals s.p.a. ceo · nwphf OTC · newron pharmaceuticals s.p.a. headquarters · newron pharmaceuticals s.p.a. business segments

About Stock Overview & Key Data

Newron Pharmaceuticals S.p.A. (NWPHF) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 30, 2017. As of the latest trading session, NWPHF stock price is $20.00, with a market capitalization of $416.1M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.

In fiscal year 2024, Newron Pharmaceuticals S.p.A. reported revenue of $51.4M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Newron Pharmaceuticals S.p.A. (NWPHF) stock price is $20.00. The stock is traded on OTC under the ticker symbol NWPHF. The 52-week range is $9.36 – $20.00.

NWPHF stock priceNWPHF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice